News

Data on chronic postoperative knee pain to be highlighted as a top abstract along with a first-ever look at SPRINT PNS in ...
New research from the University of Sydney reveals surgically implanted spinal cord stimulators—a common treatment for lower back pain which aims to disrupt pain signals traveling to the brain—are ...
OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to ...
A neuronal mechanism pumps the brakes on pain, but failure of these brakes can cause long-lasting pain. The discovery could ...
Let’s face it: pain sucks, whether you’ve got a stiff neck from sleeping weird or mysterious aches that show up just because.
Patients with a mysterious eye pain disease may be one step closer to seeing the first approved treatment for their condition ...
This policy shift moves Nalu from its prior classification of "Investigational/Experimental" to "Medically Necessary" for eligible patients-opening access to more than 22 million additional covered ...
But for many, the relief from chronic pain outweighs those little annoyances.New study: What did researchers do and find?A ...
This randomized, double-masked, placebo-controlled, Phase 2 Proof-of-Concept trial of urcosimod to treat NCP was conducted at a single trial site at Tufts Medical Center in Boston, MA, with Pedram ...
In my Reviews, I explain how I went from constant tingling to renewed energy - see the exact timeline of my progress ...
Researchers recently created a guide to help primary care clinicians navigate the complexities of chronic, nociplastic pain ...